NCT06754475

Brief Summary

This study was planned to investigate the effects of upper extremity low-volume high-intensity interval training (LV-HIIT) on physical and cognitive function in patients with heart failure with preserved ejection fraction(HFpEF).The research was planned as a randomized controlled trial. Patients with clinically stable HFpEF at cardiology clinic will be included in the study. These cases will be randomly divided into two groups: intervention group and control grup. After 8 weeks intervention physical functions before and after treatment; functional exercise capacity, arm exercise capacities , peripheral muscle strength , fatigue cognitive functions; anxiety and depression and fear of movement will be evaluated.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
7mo left

Started Nov 2024

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress73%
Nov 2024Dec 2026

Study Start

First participant enrolled

November 1, 2024

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

December 23, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

December 31, 2024

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2026

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

January 3, 2025

Status Verified

November 1, 2024

Enrollment Period

2 years

First QC Date

December 23, 2024

Last Update Submit

January 2, 2025

Conditions

Keywords

high intensity interval trainingupper extremityexercises capacity

Outcome Measures

Primary Outcomes (7)

  • maximal arm exercises capacity

    maximal arm exercises capacity will measurement with arm ergometer test.

    At baseline and after 8 week

  • Functional capacity

    Functional capacity will be assessed with the six-minute walk test (6MWT).

    At baseline and after 8 week

  • Upper extremity muscle strength

    Upper extremity muscle strength will be evaluated with a digital dynamometer and hand grip strength will be evaluated with a jamar.

    At baseline and after 8 week

  • reaction time

    The auditory and visual reaction times of the individuals will be determined. The instrument used during the test can give three stimuli and consists of two parts, In measuring the reaction times, care will be taken to ensure that the measurement area is a noiseless and light-receiving environment. Individuals will be told the technique of the test and will be asked to make 1 attempt against sound and light stimulation. After the trial, 3 measurements will be taken and the results will be recorded in milliseconds

    At baseline and after 8 week

  • cognitive function

    Mini mental Questionaire will use. Min 24 point is the cut of for this test

    At baseline and after 8 week

  • Postural sway

    The postural oscillations of the patients will be evaluated with the body oscillation device, which measures the oscillation in two axes. In this test, the participant will be asked to stand in the upright position with a distance of 10 cm between the two feet and to maintain your upright position for 30 seconds. The participant will be measured twice with the eyes open and closed. With these measurements, the mediolateral and anteroposterior oscillation distances of the patients will be measured and recorded on the computer

    At baseline and after 8 week

  • heart rate variablity

    At baseline and after 8 week

Secondary Outcomes (3)

  • hand steadness

    At baseline and after 8 week

  • Anxiety and depresion

    At baseline and after 8 week

  • activities of daily living

    At baseline and after 8 week

Study Arms (2)

Patients

EXPERIMENTAL

İntervention Group: LV-HIIT

Other: Low-volume, high-intensity interval training

Control group

OTHER

Control group

Drug: Standart medical treatment

Interventions

Low-volume, high-intensity interval training with an arm ergometer will be given two days a week for a total of eight weeks.

Patients

Standart medical teatment

Control group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Clinical condition stable for ≥4 weeks.
  • New York Heart Association functional classification I-II to III
  • Over 18 years old

You may not qualify if:

  • History of CABG surgery
  • Unstable angina pectoris
  • Severe arrhythmia
  • Acute pericarditis, endocarditis, myocarditis
  • Severe left ventricular failure (EF \<40%)
  • Acute pulmonary embolism
  • History of syncope
  • Dissecting aneurysm
  • Thrombophlebitis
  • Orthopedic disorders that may interfere with exercise
  • Uncontrolled hypertension, severe pulmonary arterial hypertension
  • Moderate-severe valve disease
  • Decompensated Congestive Heart Failure
  • Electrolyte abnormalities
  • Hypertrophic Cardiomyopathy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Tarsus University, TARSUS, Mersin

Mersin, Mersin, Turkey (Türkiye)

RECRUITING

Nurel Ertürk, TARSUS, Mersin

Yenişehir, Mersin, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Heart FailureMotor Activity

Interventions

High-Intensity Interval Training

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular DiseasesBehavior

Intervention Hierarchy (Ancestors)

Physical Conditioning, HumanExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Central Study Contacts

Nurel ERTÜRK

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomised controlled trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assist. Prof.

Study Record Dates

First Submitted

December 23, 2024

First Posted

December 31, 2024

Study Start

November 1, 2024

Primary Completion (Estimated)

November 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

January 3, 2025

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will not share

All IPD collected throughout the trial, only IPD used in the results publication

Locations